Genetic variability in response to Aβ deposition influences Alzheimer’s risk
暂无分享,去创建一个
F. Edwards | J. Hardy | Sevinc Bayram | K. Morgan | M. Shoai | M. Ryten | M. Matarin | V. Escott-Price | D. Salih | D. Cummings | J. Botía | R. Reynolds | J. Brenton | K. Brookes | T. Guetta-Baranés | David Zhang | Manuel S. Guelfi | Runil Shah | E. Bellou | T. Guetta‐Baranés | R. Shah | Tamar Guetta‐Baranés | J. Hardy
[1] Young-Joon Kim,et al. OAS1 and OAS3 negatively regulate the expression of chemokines and interferon-responsive genes in human macrophages , 2019, BMB reports.
[2] Hans-Ulrich Klein,et al. Descriptor : A multi-omic atlas of the human frontal cortex for aging and Alzheimer ’ s disease research , 2018 .
[3] R. Ransohoff,et al. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer’s disease , 2018, Molecular Neurodegeneration.
[4] J. Gallacher,et al. Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing , 2018, bioRxiv.
[5] I. Módy,et al. Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models , 2018, Neuron.
[6] M. Colonna,et al. Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism , 2018, The Journal of experimental medicine.
[7] M. Narici,et al. Dysregulation of C-X-C motif ligand 10 during aging and association with cognitive performance , 2018, Neurobiology of Aging.
[8] W. M. van der Flier,et al. Genetic meta-analysis identifies 9 novel loci and functional pathways for Alzheimer’s disease risk , 2018, bioRxiv.
[9] Kaur Alasoo,et al. Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response , 2018, Nature Genetics.
[10] R. Marioni,et al. GWAS on family history of Alzheimer’s disease , 2018, bioRxiv.
[11] Thawfeek M. Varusai,et al. The Reactome Pathway Knowledgebase , 2017, Nucleic acids research.
[12] J. Schug,et al. Integrated approach reveals diet, APOE genotype and sex affect immune response in APP mice. , 2018, Biochimica et biophysica acta. Molecular basis of disease.
[13] T. Iwaki,et al. Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation , 2017, Scientific Reports.
[14] Nick C Fox,et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.
[15] K. Hao,et al. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease , 2017, Nature Neuroscience.
[16] I. Amit,et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.
[17] W. Wurst,et al. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury , 2017, EMBO reports.
[18] John Hardy,et al. An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks , 2017, BMC Systems Biology.
[19] Rob Patro,et al. Salmon provides fast and bias-aware quantification of transcript expression , 2017, Nature Methods.
[20] Joseph K. Pickrell,et al. Genetic regulatory effects modified by immune activation contribute to autoimmune disease associations , 2017, Nature Communications.
[21] E. Hol,et al. Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease. , 2016, Biochimica et biophysica acta.
[22] Ben A. Barres,et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models , 2016, Science.
[23] Mariana Vargas-Caballero,et al. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology , 2016, Brain : a journal of neurology.
[24] Minoru Kanehisa,et al. KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..
[25] M. Robinson,et al. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. , 2015, F1000Research.
[26] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[27] Stein Aerts,et al. i-cisTarget 2015 update: generalized cis-regulatory enrichment analysis in human, mouse and fly , 2015, Nucleic Acids Res..
[28] D. Holtzman,et al. TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.
[29] F. Edwards,et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. , 2015, Cell reports.
[30] M. Heneka,et al. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model. , 2015, The Journal of clinical investigation.
[31] J. Satoh,et al. A Comprehensive Profile of ChIP-Seq-Based PU.1/Spi1 Target Genes in Microglia , 2014, Gene regulation and systems biology.
[32] A. Singleton,et al. Genetic variability in the regulation of gene expression in ten regions of the human brain , 2014, Nature Neuroscience.
[33] Nick C Fox,et al. Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease , 2014, PLoS ONE.
[34] C. Wallace,et al. Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.
[35] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[36] Jennifer M. Pocock,et al. Insights into TREM2 biology by network analysis of human brain gene expression data , 2013, Neurobiology of Aging.
[37] Keith A. Johnson,et al. CD33 Alzheimer’s disease locus: Altered monocyte function and amyloid biology , 2013, Nature Neuroscience.
[38] Bradley T. Hyman,et al. Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta , 2013, Neuron.
[39] E. Hol,et al. Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe/PS1dE9 Alzheimer's disease mouse model , 2013, Neurobiology of Aging.
[40] L. Tran,et al. Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.
[41] J. Donovan,et al. Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1 , 2013, Proceedings of the National Academy of Sciences.
[42] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[43] M. Heneka,et al. NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.
[44] J. Schneider,et al. Overview and findings from the religious orders study. , 2012, Current Alzheimer research.
[45] J. Schneider,et al. Overview and findings from the rush Memory and Aging Project. , 2012, Current Alzheimer research.
[46] Sampath Prahalad,et al. Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases. , 2012, Autoimmunity reviews.
[47] Seth Love,et al. Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease , 2010, PloS one.
[48] K. Elliott,et al. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. , 2009, Human molecular genetics.
[49] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[50] B. Winblad,et al. Decreased Fractalkine and Increased IP-10 Expression in Aged Brain of APPswe Transgenic Mice , 2008, Neurochemical Research.
[51] John D. Storey,et al. Capturing Heterogeneity in Gene Expression Studies by Surrogate Variable Analysis , 2007, PLoS genetics.
[52] Hedi Peterson,et al. g:Profiler—a web-based toolset for functional profiling of gene lists from large-scale experiments , 2007, Nucleic Acids Res..
[53] V. Moskvina,et al. Detailed Analysis of the Relative Power of Direct and Indirect Association Studies and the Implications for Their Interpretation , 2007, Human Heredity.
[54] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[55] S. Horvath,et al. Conservation and evolution of gene coexpression networks in human and chimpanzee brains , 2006, Proceedings of the National Academy of Sciences.
[56] S. Horvath,et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target , 2006, Proceedings of the National Academy of Sciences.
[57] S. Horvath,et al. Statistical Applications in Genetics and Molecular Biology , 2011 .
[58] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[59] C. Lemere,et al. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. , 2001, The American journal of pathology.